These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 12483411)

  • 21. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
    Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N
    Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.
    Hoshikawa H; Mori T; Kishino T; Yamamoto Y; Inamoto R; Akiyama K; Mori N; Nishiyama Y
    Ann Nucl Med; 2013 May; 27(4):363-70. PubMed ID: 23378102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.
    Amthauer H; Denecke T; Rau B; Hildebrandt B; Hünerbein M; Ruf J; Schneider U; Gutberlet M; Schlag PM; Felix R; Wust P
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):811-9. PubMed ID: 14762698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.
    Yao M; Luo P; Hoffman HT; Chang K; Graham MM; Menda Y; Tan H; Buatti JM
    Am J Clin Oncol; 2007 Jun; 30(3):264-70. PubMed ID: 17551303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
    Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
    Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of [N-methyl-11C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET.
    Sutinen E; Jyrkkiö S; Alanen K; Någren K; Minn H
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):72-7. PubMed ID: 12483412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic significance of FDG-PET and argyrophilic nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma.
    Nakamura M; Sano K; Kitagawa Y; Ogasawara T; Nishizawa S; Yonekura Y
    Oral Oncol; 2004 Feb; 40(2):190-8. PubMed ID: 14693244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.
    Li SJ; Guo W; Ren GX; Huang G; Chen T; Song SL
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):180-186. PubMed ID: 18093707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.
    Capirci C; Rubello D; Pasini F; Galeotti F; Bianchini E; Del Favero G; Panzavolta R; Crepaldi G; Rampin L; Facci E; Gava M; Banti E; Marano G
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1461-9. PubMed ID: 19419820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET.
    Nam SY; Lee SW; Im KC; Kim JS; Kim SY; Choi SH; Ryu JS; Moon DH; Oh SJ; Yi BY; Kim JH; Ahn SD; Shin SS; Kim SB; Choi EK; Lee BJ
    Oral Oncol; 2005 Apr; 41(4):390-5. PubMed ID: 15792611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.
    Prestwich RJ; Subesinghe M; Gilbert A; Chowdhury FU; Sen M; Scarsbrook AF
    Clin Radiol; 2012 Oct; 67(10):966-75. PubMed ID: 22595082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET.
    Hoshikawa H; Mitani T; Nishiyama Y; Yamamoto Y; Ohkawa M; Mori N
    Auris Nasus Larynx; 2009 Apr; 36(2):192-8. PubMed ID: 18606510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancer.
    Slevin NJ; Collins CD; Hastings DL; Waller ML; Johnson RJ; Cowan RA; Birzgalis AR; Farrington WT; Swindell R
    J Laryngol Otol; 1999 Jun; 113(6):548-54. PubMed ID: 10605586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different distribution of (62) Cu ATSM and (18)F-FDG in head and neck cancers.
    Kositwattanarerk A; Oh M; Kudo T; Kiyono Y; Mori T; Kimura Y; Maruyama R; Fujibayashi Y; Fujieda S; Okazawa H
    Clin Nucl Med; 2012 Mar; 37(3):252-7. PubMed ID: 22310251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
    Imsande HM; Davison JM; Truong MT; Devaiah AK; Mercier GA; Ozonoff AJ; Subramaniam RM
    AJR Am J Roentgenol; 2011 Oct; 197(4):976-80. PubMed ID: 21940588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
    Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O
    Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose.
    Allal AS; Slosman DO; Kebdani T; Allaoua M; Lehmann W; Dulguerov P
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1295-300. PubMed ID: 15275712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma.
    Brink I; Hentschel M; Bley TA; Walch A; Mix M; Kleimaier M; Moser E; Imdahl A
    Eur J Surg Oncol; 2004 Jun; 30(5):544-50. PubMed ID: 15135484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-[11C]-acetate PET imaging in head and neck cancer--a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning.
    Sun A; Sörensen J; Karlsson M; Turesson I; Langström B; Nilsson P; Cederblad L; Bertling J; Riklund K; Johansson S
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):651-657. PubMed ID: 17146654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.